Urothelial Carcinoma trials recruiting in Michigan

All Urothelial Carcinoma trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
  NCT06695845 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• A Study of MT-4561 in Patients With Various Advanced Solid Tumors
  NCT06943521 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Grand Rapids
• DBC-664 in Adult Patients With Solid Tumors
  NCT07705035 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Grand Rapids
• Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
  NCT06293898 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
  NCT03452774 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Michigan: Ann Arbor, Lansing
• Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
  NCT06966024 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
  NCT04198766 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit, Grand Rapids